|
Volumn 16, Issue 4, 2010, Pages 1341-
|
Vascular endothelial growth factor concentration as a predictive marker: Ready for primetime? [1]
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
EDETIC ACID;
VANDETANIB;
VASCULOTROPIN;
N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 ((1 METHYLPIPERIDIN 4 YL)METHOXY)QUINAZOLIN 4 AMINE;
N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYLPIPERIDIN-4-YL)METHOXY)QUINAZOLIN-4-AMINE;
PIPERIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
TUMOR MARKER;
VASCULOTROPIN RECEPTOR;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
BLOOD SAMPLING;
CLINICAL PRACTICE;
CONCENTRATION (PARAMETERS);
DEMOGRAPHY;
HUMAN;
LETTER;
ORAL CONTRACEPTION;
PREDICTOR VARIABLE;
PRIORITY JOURNAL;
THROMBOCYTE COUNT;
BLOOD;
BLOOD ANALYSIS;
DRUG ANTAGONISM;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METHODOLOGY;
NOTE;
PREDICTION AND FORECASTING;
TREATMENT OUTCOME;
BLOOD CHEMICAL ANALYSIS;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
PIPERIDINES;
PREDICTIVE VALUE OF TESTS;
QUINAZOLINES;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 76749132197
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: 10.1158/1078-0432.CCR-09-1476 Document Type: Letter |
Times cited : (3)
|
References (4)
|